Bill
HR 3391
The End Price Gouging for Medications Act prohibits excessive medication price hikes, ensuring affordable access for patients, especially during emergencies.
Bill Number: HR 3391
Title: End Price Gouging for Medications Act
Status: Introduced in House
Introduced Date: May 14, 2025
Primary Sponsor: Debbie Dingell
The End Price Gouging for Medications Act aims to address the rising costs of medications by prohibiting price gouging practices within the pharmaceutical industry. The bill seeks to ensure that patients have access to affordable medications, particularly during public health emergencies or significant market disruptions.
While the specific text of the bill has not been detailed in the provided information, the following key provisions are typically expected in legislation aimed at curbing price gouging:
Definition of Price Gouging: Establishes a clear definition of what constitutes price gouging in the context of medications, likely including criteria such as excessive price increases during emergencies.
Enforcement Mechanisms: Outlines the enforcement mechanisms that would be put in place to monitor and penalize pharmaceutical companies that engage in price gouging practices.
Reporting Requirements: May require pharmaceutical companies to report pricing changes and justifications to regulatory bodies to ensure transparency.
Consumer Protections: Introduces protections for consumers, ensuring they are not subjected to exorbitant prices for essential medications.
The bill would primarily affect:
- Pharmaceutical Companies: Those involved in the production and distribution of medications would be subject to new regulations and potential penalties for price gouging.
- Consumers: Patients and healthcare consumers would benefit from reduced medication costs and increased access to necessary treatments.
- Healthcare Providers: Providers may see changes in prescription practices and patient access to medications.
Committee Referrals: Upon introduction, HR 3391 was referred to the Committee on Energy and Commerce, as well as additional committees including Ways and Means, Armed Services, Veterans' Affairs, Oversight and Government Reform, and Natural Resources. Each committee will review provisions relevant to their jurisdiction.
Timeline: The timeline for further actions and discussions within the committees will be determined by the Speaker of the House.
The End Price Gouging for Medications Act represents a significant legislative effort to combat the rising costs of medications and protect consumers from unfair pricing practices. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and potential impact on the pharmaceutical industry and healthcare consumers.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
